高水平放疗医师选择或可改善鼻咽癌预后
该研究纳入1140例新诊断鼻咽癌患者,依据主治医师3年总生存将其分为高、中、低水平三组,比较预后差异。结果显示三组3年OS分别为92.9%、87.7%、83.5%(p=0.003),倾向性评分匹配后仍存在显著差异,医师因素对死亡风险的归因风险为17.66%。结论提示患者预后部分归因于医师水平差异。
要点
- 高、中、低水平医师组3年OS分别为92.9%、87.7%、83.5%(p=0.003)
- 倾向性评分匹配后三组3年OS仍显著差异(p=0.004)
- 医师因素对死亡风险的归因风险为17.66%(95%CI 5.39-44.65%)
核心结论
- 不同临床放疗医师治疗的鼻咽癌患者预后存在明显差异,预后变异部分归因于医师间差异。
- 预后风险最大份额在患者层面,但医师因素亦独立贡献于死亡风险。
研究设计与样本
- 回顾性收集1140例新诊断鼻咽癌患者的临床数据。
- 依据主治医师的3年总生存将医师分为高水平、中水平、低水平三组。
- 采用Cox比例风险回归分析预后因素,倾向性评分匹配(PSM)减少混杂影响,交互风险归因程序(IRAP)计算归因风险。
主要发现
- 高、中、低水平组3年OS分别为92.9%、87.7%、83.5%(p=0.003)。
- PSM后三组3年OS分别为92.4%、87.4%、82.9%(p=0.004)。
- 多因素调整后,患者相关因素(包括肿瘤)占死亡风险的90.02%(95%CI 73.43-96.84%)。
- 医师因素占死亡风险的17.66%(95%CI 5.39-44.65%)。
- 所有相关因素合计占死亡风险的92.02%(95%CI 77.83-97.43%)。
临床怎么用
- 鼻咽癌放疗预后不仅取决于患者因素,医师水平差异亦影响结局,提示应关注医师培训与经验积累。
- 医师因素归因风险达17.66%,临床选择高水平医师或有助于改善鼻咽癌患者预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To assess the relationship between the level of clinical radiation oncologist and the prognosis of patients with nasopharyngeal carcinoma (NPC). To our knowledge, no previous study has explicitly assessed the relationship with cancer prognosis and clinical radiation oncologists level. The effect of physicians on the prognosis has been entirely ignored. METHODS: Clinical data were collected for 1140 patients with newly diagnosed NPC. Based on the 3-year overall survival, the treating physicians were classified into 3 grades: high-level group, medium-level group, and low-level group. Cox proportional hazards regression analysis was used to assess the independent significance of different prognostic factors. Propensity score matching (PSM) was used to minimize the influence of confounders so that difference in outcomes provides an unbiased estimate of the influence of physician. Interactive Risk Attributable Program (IRAP) was used to calculate the attribution risk of individual risk factors or a combination of multiple factors. RESULTS: The 3-year OS in the high-level, medium-level, and low-level groups was 92.9%, 87.7%, and 83.5%, respectively (p = 0.003). After propensity score matching, the 3-year OS was 92.4%, 87.4%, and 82.9%, respectively (p = 0.004). IRAP was used to calculate the attribution risk of mortality risk. After multivariable adjustment, patient-related factors including tumor accounted for 90.02% [95% confidence interval (CI), 73.43-96.84%) and physician factors accounted for 17.66% (95% CI, 5.39-44.65%) of the mortalityrisk. All related factors, including patient-related factors and physician factors accounted for 92.02% (95% CI, 77.83-97.43%). CONCLUSION: Our study demonstrated obvious differences in the prognosis of patients treated by various clinical radiation oncologists. The largest share of prognosis risk was found to be at the patient level, while variation in prognosis was, in part, attributable to differences among physicians.
引用
- Fei Z, Qiu X, Li Y, et al. Selection of a high-level physician may help improve outcomes of nasopharyngeal carcinoma. Radiother Oncol. 2020. PMID: 32294606. doi:10.1016/j.radonc.2020.03.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。